JOINT FILING AGREEMENT
Exhibit 99.3
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D dated August 7, 2017 (including amendments thereto) with respect to the shares of Ordinary Shares, par value NIS 0.10 per share, of BioLineRx Ltd. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: August 7, 2017
| BIOTECHNOLOGY VALUE FUND, L.P. | BVF INC. | |||
| By: | BVF Partners L.P., its general partner | By: |
/s/ Xxxx X. Xxxxxxx | |
| By: | BVF Inc., its general partner | Xxxx X. Xxxxxxx | ||
| President | ||||
| By: |
/s/ Xxxx X. Xxxxxxx |
|||
| Xxxx X. Xxxxxxx | ||||
| President |
/s/ Xxxx X. Xxxxxxx | |||
| XXXX X. XXXXXXX | ||||
| BIOTECHNOLOGY VALUE FUND II, L.P. | ||||
| By: | BVF Partners L.P., its general partner | |||
| By: | BVF Inc., its general partner | |||
| By: |
/s/ Xxxx X. Xxxxxxx |
|||
| Xxxx X. Xxxxxxx | ||||
| President | ||||
| BVF PARTNERS L.P. | ||||
| By: | BVF Inc., its general partner | |||
| By: |
/s/ Xxxx X. Xxxxxxx |
|||
| Xxxx X. Xxxxxxx | ||||
| President | ||||
| BVF PARTNERS OS LTD. | ||
| By: | BVF Partners L.P., its sole member | |
| By: | BVF Inc., its general partner | |
| By: |
/s/ Xxxx X. Xxxxxxx |
|
| Xxxx X. Xxxxxxx | ||
| President | ||
| Biotechnology Value Trading Fund OS LP | ||
| By: | BVF Partners L.P., its investment manager | |
| By: | BVF Inc., its general partner | |
| By: |
/s/ Xxxx X. Xxxxxxx |
|
| Xxxx X. Xxxxxxx | ||
| President | ||
